시장보고서

상품코드

1485783

무균 주사제 시장 : 약제 유형별, 용도별, 투여 경로별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Sterile Injectables Market, By Drug Type, By Application, By Route of Administration, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 03월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 284 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

리포트 하이라이트

무균 주사제 시장 규모는 2023년에 129억 8,254만 달러에 달하며, 2024-2032년 CAGR 12.43%로 확대

무균 주사제 시장 - 시장 역학

고령화와 만성질환의 증가

암, 당뇨병, 자가면역질환과 같은 만성질환의 발병률 증가는 치료 및 관리를 위한 무균 주사제에 대한 수요를 촉진하고 있습니다. 또한 만성질환을 치료하기 위해 새로운 기술을 혁신하는 제약 회사가 증가하고 있으며, 이는 예측 기간 중 시장 성장을 가속하고 있습니다. 또한 새로운 기술에 대한 FDA의 승인은 무균 주사제에 대한 접근성을 향상시키고 있습니다. 혁신적인 생명과학 및 소비재 기업은 신제품을 시장에 출시하고, 라벨링 및 홍보를 통해 제품을 판매하며, FDA(식품의약국) 규제와 끊임없이 확대되고 진화하는 법률에 따라 시판 후 규정 준수를 보장하는 복잡한 규제를 성공적으로 통과해야 합니다.

무균주사제 시장 - 주요 인사이트

리서치 애널리스트의 분석에 따르면 세계 시장은 예측 기간(2024-2032년) 동안 매년 약 12.43%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

약물 유형별로는 사이토카인이 2023년 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.

용도별로는 암이 2023년 주요 유형으로 나타났습니다.

최종사용자별로는 2023년 바이오 제약회사가 주요 유형이었습니다.

지역별로는 북미가 2023년 매출에서 선두를 차지했습니다.

무균 주사제 시장 - 세분화 분석 :

무균 주사제 세계 시장은 약물 유형, 용도, 투여 경로, 최종사용자 및 지역에 따라 세분화됩니다.

시장은 용도에 따라 암, 당뇨병, 심혈관 질환, 중추신경계 질환, 감염, 근골격계, 기타 등 7가지 범주로 나뉩니다. 암 치료에서 무균 주사제는 일반적으로 화학요법 약물을 혈류에 직접 투여하는 데 사용됩니다. 이 약물은 몸 전체를 순환하여 암세포를 표적으로 삼아 파괴합니다. 일부 GLP-1 수용체 작용제와 같이 당뇨병을 관리하는 데 사용되는 일부 약물은 무균 주사제를 통해 투여됩니다.

시장은 최종사용자에 따라 두 가지 범주로 나뉩니다: 무균 주사제는 제약회사와 바이오 제약회사에서 약물을 혈류와 조직에 직접 투여하는 데 중요한 역할을 합니다. 바이오 제약 기업에서 무균 주사제는 단클론 항체, 백신, 세포 치료와 같은 생물학적 약물의 전달에 사용됩니다.

무균 주사제 시장 - 지역적 인사이트

지역적으로 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카에 분포되어 있습니다. 이 지역들은 다시 사업 진출 국가에 따라 세분화되어 있습니다.

아시아태평양은 아시아 국가들의 비용 절감 기회와 인도와 중국의 우호적인 규제 정책으로 인해 가장 매력적인 시장으로 부상하고 있습니다. 또한 중국내 바이오제약 및 제약회사들이 이 지역 시장 성장을 지원하고 있습니다. 무균 주사제 제조업체들은 무균 주사제 제품 포트폴리오를 확대하기 위해 합병 및 인수합병 등의 전략을 채택하고 있습니다. 또한 제약 및 생명과학 기업의 R&D 투자 증가는 향후 무균 주사제에 대한 수요를 증가시킬 것으로 예상됩니다.

무균주사제 시장 - 경쟁 구도:

무균 주사제 개발 신흥 시장은 무균 주사제 제품 포트폴리오를 확대하기 위해 M&A와 같은 전략을 채택하고 있으며, 이는 예측 기간 중 세계 무균 주사제 시장의 성장을 가속할 것으로 예상됩니다, Recipharm AB, Aenova Group, Fresenius Kabi, Famar와 같은 주요 기업은 최신 시장 동향과 제조 공정 개선을 포함한 기술 발전에 따라 세계 사업에서 입지를 다지고 있습니다.

서론
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제12장 주요 벤더 분석 : 무균 주사제업계

경쟁 대시보드
기업 개요
- Baxter
- Catalent, Inc.
- Vetter Pharma
- Recipharm AB
- Aenova Group
- Fresenius Kabi
- Unither Pharmaceuticals
- Famar
- Cipla Inc.
- NextPharma Technologies
- 기타

제13장 애널리스트의 전방위 전망

KSA 24.06.04

REPORT HIGHLIGHT

Sterile Injectables Market size was valued at USD 12,982.54 Million in 2023, expanding at a CAGR of 12.43% from 2024 to 2032.

Sterile injectables are medications and other therapeutic products that are administered directly into the bloodstream or tissues of the body. As the global population ages, there's a greater demand for injectable medications, particularly for conditions prevalent in older adults such as arthritis, cardiovascular diseases, and neurological disorders. However, regulatory approvals for sterile injectable drugs are stringent due to safety concerns associated with injectable formulations. Meeting these requirements can be time-consuming and costly, hindering market growth. Furthermore, advances in drug delivery systems and techniques, such as prefilled syringes and auto-injectors, enhance patient convenience, compliance, and safety, thereby driving the demand for sterile injectable products.

Sterile Injectables Market- Market Dynamics

Increasing aging population and prevalence of chronic diseases

The rising incidence of chronic diseases such as cancer, diabetes, and autoimmune disorders fuels the demand for sterile injectable medications for treatment and management. In addition, an increase in several pharmaceutical companies are innovating novel techniques to treat chronic diseases, leading to fueling the market growth over the forecasting period. Additionally, approval by the FDA for novel techniques is improving access to sterile injectables. Innovative life sciences and consumer product companies must successfully navigate the regulatory complexities of introducing new products to the market, labeling and promoting those products, and ensuring post-marketing compliance with the Food and Drug Administration (FDA) regulations and an ever-expanding body of evolving laws.

Sterile Injectables Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.43% over the forecast period (2024-2032)

Based on drug type segmentation, Cytokines was predicted to show maximum market share in the year 2023

Based on application segmentation, Cancer was the leading type in 2023

Based on end-user segmentation, Biopharmaceutical Companies was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Sterile Injectables Market- Segmentation Analysis:

The Global Sterile Injectables Market is segmented on the basis of Drug Type, Application, Route of Administration, and End User and Region.

The market is divided into seven categories based on application: Cancer, diabetes, cardiovascular diseases, central nervous system diseases, infectious disorders, musculoskeletal, and Others. In cancer treatment, sterile injectables are commonly used to administer chemotherapy drugs directly into the bloodstream. These drugs circulate throughout the body, targeting and destroying cancer cells. Some medications used to manage diabetes, such as certain types of GLP-1 receptor agonists, are administered via sterile injectables.

The market is divided into two categories based on end-user: Sterile injectables play a crucial role in pharmaceutical and biopharmaceutical companies for delivering medications directly into the bloodstream or tissues. In biopharmaceutical companies, sterile injectables are used for the delivery of biological drugs, such as monoclonal antibodies, vaccines, and cell therapies.

Sterile Injectables Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Asia Pacific is the most attractive market due to cost-saving opportunities in Asian countries and supportive regulatory policies, in India and China. In addition, China's domestic biopharmaceutical & pharmaceutical companies a supporting the region's market growth. Manufacturers of sterile injectables are adopting strategies including mergers and acquisitions, to expand their sterile injectables product portfolio. In addition, increasing R&D investments by pharmaceutical companies and life sciences will increase demand for sterile injectables in the future.

Sterile Injectables Market- Competitive Landscape:

Manufacturers developing sterile injectables are adopting strategies such as mergers and acquisitions, to expand their sterile injectables product portfolio, which is expected to boost the global sterile injectables market growth over the forecast period. Leading players including Baxter, Catalent, Inc., Vetter Pharma, Recipharm AB, Aenova Group, Fresenius Kabi, Famar, etc. are following the latest market trends, and advances in technology including improvements in manufacturing processes to consolidate their position in global businesses.

Recent Developments:

In April 2022, Nevakar Injectables Inc. is a biopharmaceutical company announced that the U.S. Food and Drug Administration ("FDA") has approved its ready-to-use Ephedrine Sulfate Injection which is used for treating patients in the surgical setting.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL STERILE INJECTABLES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Baxter

Catalent, Inc.

Vetter Pharma

Recipharm AB

Aenova Group

Fresenius Kabi

Unither Pharmaceuticals

Famar

Cipla Inc.

NextPharma Technologies

Others

GLOBAL STERILE INJECTABLES MARKET, BY DRUG TYPE- MARKET ANALYSIS, 2019 - 2032

Monoclonal Antibodies (mAbs)
Cytokines
Insulin
Peptide Hormones
Vaccines
Immunoglobulins
Others

GLOBAL STERILE INJECTABLES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Cancer
Diabetes
Cardiovascular Diseases
Central Nervous System Diseases
Infectious Disorders
Musculoskeletal
Others

GLOBAL STERILE INJECTABLES MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

Subcutaneous (SC)
Intravenous (IV)
Intramuscular (IM)

GLOBAL STERILE INJECTABLES MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

Pharmaceutical Companies
Biopharmaceutical Companies

GLOBAL STERILE INJECTABLES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1.Sterile Injectables Market Overview

1.1.Study Scope
1.2.Market Estimation Years

2.Executive Summary

2.1.Market Snippet
- 2.1.1.Sterile Injectables Market Snippet by Drug Type
- 2.1.2.Sterile Injectables Market Snippet by Application
- 2.1.3.Sterile Injectables Market Snippet by Route Of Administration
- 2.1.4.Sterile Injectables Market Snippet by End User
- 2.1.5.Sterile Injectables Market Snippet by Country
- 2.1.6.Sterile Injectables Market Snippet by Region
2.2.Competitive Insights

3.Sterile Injectables Key Market Trends

3.1.Sterile Injectables Market Drivers
- 3.1.1.Impact Analysis of Market Drivers
3.2.Sterile Injectables Market Restraints
- 3.2.1.Impact Analysis of Market Restraints
3.3.Sterile Injectables Market Opportunities
3.4.Sterile Injectables Market Future Trends

4.Sterile Injectables Industry Study

4.1.PEST Analysis
4.2.Porter's Five Forces Analysis
4.3.Growth Prospect Mapping
4.4.Regulatory Framework Analysis

5.Sterile Injectables Market: COVID-19 Impact Analysis

5.1.Pre-COVID-19 Impact Analysis
5.2.Post-COVID-19 Impact Analysis
- 5.2.1.Top Performing Segments
- 5.2.2.Marginal Growth Segments
- 5.2.3.Top Looser Segments
- 5.2.4.Marginal Loss Segments

6.Sterile Injectables Market Landscape

6.1.Sterile Injectables Market Share Analysis, 2023
6.2.Breakdown Data, by Key Manufacturer
- 6.2.1.Established Players' Analysis
- 6.2.2.Emerging Players' Analysis

7.Sterile Injectables Market - By Drug Type

7.1.Overview
- 7.1.1.Segment Share Analysis, By Drug Type, 2023 & 2032 (%)
- 7.1.2.Monoclonal Antibodies (mAbs)
- 7.1.3.Cytokines
- 7.1.4.Insulin
- 7.1.5.Peptide Hormones
- 7.1.6.Vaccines
- 7.1.7.Immunoglobulins
- 7.1.8.Others

8.Sterile Injectables Market - By Application

8.1.Overview
- 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
- 8.1.2.Cancer
- 8.1.3.Diabetes
- 8.1.4.Cardiovascular Diseases
- 8.1.5.Central Nervous System Diseases
- 8.1.6.Infectious Disorders
- 8.1.7.Musculoskeletal
- 8.1.8.Others

9.Sterile Injectables Market - By Route Of Administration

9.1.Overview
- 9.1.1.Segment Share Analysis, By Route Of Administration, 2023 & 2032 (%)
- 9.1.2.Subcutaneous (SC)
- 9.1.3.Intravenous (IV)
- 9.1.4.Intramuscular (IM)

10.Sterile Injectables Market - By End User

10.1.Overview
- 10.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
- 10.1.2.Pharmaceutical Companies
- 10.1.3.Biopharmaceutical Companies

11.Sterile Injectables Market- By Geography

11.1.Introduction
- 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
11.2.North America
- 11.2.1.Overview
- 11.2.2.Sterile Injectables Key Manufacturers in North America
- 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4.North America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 11.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.6.North America Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
- 11.2.7.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.2.8.U.S.
  - 11.2.8.1.Overview
  - 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3.U.S. Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.2.8.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.2.8.5.U.S. Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.2.8.6.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.2.9.Canada
  - 11.2.9.1.Overview
  - 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3.Canada Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.2.9.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.2.9.5.Canada Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.2.9.6.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.Europe
- 11.3.1.Overview
- 11.3.2.Sterile Injectables Key Manufacturers in Europe
- 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4.Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 11.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.6.Europe Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
- 11.3.7.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.8.Germany
  - 11.3.8.1.Overview
  - 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3.Germany Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.3.8.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.8.5.Germany Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.3.8.6.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.9.Italy
  - 11.3.9.1.Overview
  - 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3.Italy Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.3.9.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.9.5.Italy Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.3.9.6.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.10.United Kingdom
  - 11.3.10.1.Overview
  - 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3.United Kingdom Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.3.10.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.10.5.United Kingdom Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.3.10.6.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.11.France
  - 11.3.11.1.Overview
  - 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3.France Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.3.11.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.11.5.France Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.3.11.6.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.12.Russia
  - 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.2.Russia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.3.12.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.12.4.Russia Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.3.12.5.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.13.Netherlands
  - 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.2.Netherlands Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.3.13.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.13.4.Netherlands Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.3.13.5.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.14.Sweden
  - 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.2.Sweden Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.3.14.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.14.4.Sweden Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.3.14.5.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.15.Poland
  - 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.2.Poland Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.3.15.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.15.4.Poland Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.3.15.5.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.16.Rest of Europe
  - 11.3.16.1.Overview
  - 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3.Rest of the Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.3.16.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.16.5.Rest of the Europe Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.3.16.6.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.Asia Pacific (APAC)
- 11.4.1.Overview
- 11.4.2.Sterile Injectables Key Manufacturers in Asia Pacific
- 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4.Asia Pacific Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 11.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.6.Asia Pacific Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
- 11.4.7.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.8.India
  - 11.4.8.1.Overview
  - 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3.India Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.4.8.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.8.5.India Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.4.8.6.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.9.China
  - 11.4.9.1.Overview
  - 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3.China Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.4.9.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.9.5.China Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.4.9.6.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.10.Japan
  - 11.4.10.1.Overview
  - 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3.Japan Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.4.10.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.10.5.Japan Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.4.10.6.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.11.South Korea
  - 11.4.11.1.Overview
  - 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3.South Korea Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.4.11.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.11.5.South Korea Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.4.11.6.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.12.Australia
  - 11.4.12.1.Overview
  - 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3.Australia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.4.12.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.12.5.Australia Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.4.12.6.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.13.Thailand
  - 11.4.13.1.Overview
  - 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3.Thailand Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.4.13.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.13.5.Thailand Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.4.13.6.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.14.Indonesia
  - 11.4.14.1.Overview
  - 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3.Indonesia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.4.14.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.14.5.Indonesia Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.4.14.6.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.15.Philippines
  - 11.4.15.1.Overview
  - 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3.Philippines Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.4.15.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.15.5.Philippines Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.4.15.6.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.16.Rest of APAC
  - 11.4.16.1.Overview
  - 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3.Rest of APAC Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.4.16.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.16.5.Rest of APAC Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.4.16.6.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.Latin America
- 11.5.1.Overview
- 11.5.2.Sterile Injectables Key Manufacturers in Latin America
- 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4.Latin America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 11.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.6.Latin America Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
- 11.5.7.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.8.Brazil
  - 11.5.8.1.Overview
  - 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3.Brazil Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.5.8.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.8.5.Brazil Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.5.8.6.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.9.Mexico
  - 11.5.9.1.Overview
  - 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3.Mexico Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.5.9.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.9.5.Mexico Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.5.9.6.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.10.Argentina
  - 11.5.10.1.Overview
  - 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3.Argentina Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.5.10.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.10.5.Argentina Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.5.10.6.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.11.Colombia
  - 11.5.11.1.Overview
  - 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3.Colombia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.5.11.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.11.5.Colombia Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.5.11.6.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.12.Rest of LATAM
  - 11.5.12.1.Overview
  - 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3.Rest of LATAM Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.5.12.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.12.5.Rest of LATAM Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.5.12.6.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.Middle East and Africa
- 11.6.1.Overview
- 11.6.2.Sterile Injectables Key Manufacturers in Middle East and Africa
- 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4.Middle East and Africa Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 11.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.6.Middle East and Africa Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
- 11.6.7.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.8.Saudi Arabia
  - 11.6.8.1.Overview
  - 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3.Saudi Arabia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.6.8.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.8.5.Saudi Arabia Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.6.8.6.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.9.United Arab Emirates
  - 11.6.9.1.Overview
  - 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3.United Arab Emirates Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.6.9.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.9.5.United Arab Emirates Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.6.9.6.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.10.Israel
  - 11.6.10.1.Overview
  - 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3.Israel Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.6.10.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.10.5.Israel Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.6.10.6.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.11.Turkey
  - 11.6.11.1.Overview
  - 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3.Turkey Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.6.11.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.11.5.Turkey Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.6.11.6.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.12.Algeria
  - 11.6.12.1.Overview
  - 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3.Algeria Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.6.12.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.12.5.Algeria Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.6.12.6.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.13.Egypt
  - 11.6.13.1.Overview
  - 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3.Egypt Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.6.13.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.13.5.Egypt Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.6.13.6.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.14.Rest of MEA
  - 11.6.14.1.Overview
  - 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3.Rest of MEA Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.6.14.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.14.5.Rest of MEA Market Size and Forecast, By Route Of Administration, 2019 - 2032 (US$ Million)
  - 11.6.14.6.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Sterile Injectables Industry

12.1.Competitive Dashboard
12.2.Company Profiles
- 12.2.1.Baxter
- 12.2.2.Catalent, Inc.
- 12.2.3.Vetter Pharma
- 12.2.4.Recipharm AB
- 12.2.5.Aenova Group
- 12.2.6.Fresenius Kabi
- 12.2.7.Unither Pharmaceuticals
- 12.2.8.Famar
- 12.2.9.Cipla Inc.
- 12.2.10.NextPharma Technologies
- 12.2.11.Others

13.360 Degree Analyst View

14.Appendix

14.1.Research Methodology
14.2.References
14.3.Abbreviations
14.4.Disclaimer
14.5.Contact Us